Discover how scientists developed a COVID-19 vaccine in record time using mRNA technology, leading to improved public health ...

From today, February 3, pregnant women in Australia will be eligible for a free RSV vaccine under the National Immunisation ...

A research team from POSTECH has developed a biodegradable polymer-based delivery system that efficiently transports mRNA.

With the triad of respiratory viruses present in our day-to-day, it is recommended that individuals receive both COVID-19, flu, and occasionally RSV and MPox vaccinations. However, there is a common ...

Revenue for Arexvy and Abrysvo fell sharply year over year in the fourth quarter due to narrower U.S. guidelines for their use.

Eleven drugs are poised to reach blockbuster status, dramatically improving patient outcomes on a global scale.

The bill would implement a moratorium for a decade. “I am not against vaccination in any way,” the freshman lawmaker said.

As Moderna maps out a more cautious future amid lower-than-expected sales of its current products, the company is bolstering ...

"There is no vaccine against HMPV. However, several vaccines are in the process of being developed. A combined HMPV and RSV ...

Moderna (MRNA) stock falls as Goldman Sachs downgrades the COVID-19 vaccine maker to Neutral from Buy, citing a lack of ...

Consequently, Richter believes that Moderna is uncertain about the outlook of its Covid and RSV vaccines. The analyst cut her price target on MRNA to $51 from $99. A Potential Silver Lining for ...